AbbVie Inc (MEX:ABBV)
MXN 3585.03 38.93 (1.1%) Market Cap: 6.16 Tn Enterprise Value: 7.46 Tn PE Ratio: 61.23 PB Ratio: 51.65 GF Score: 75/100

Abbvie Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 02:35PM GMT
Release Date Price: MXN2815.85 (-0.15%)
Terence C. Flynn
Morgan Stanley, Research Division - Equity Analyst

Great. Well, thanks, everybody, for joining us. I'm Terence Flynn, the U.S. pharma analyst here at Morgan Stanley. We're very pleased to be hosting AbbVie today.

First, before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that out of the way, today from the company, we have Rob Michael, Vice Chairman and President; Jeff Stewart, Executive Vice President and Chief Commercial Officer; and Neil Gallagher, Vice President, Development and Chief Medical Officer. Thank you so much for being here today. Really appreciate it. Great to see you in person.

Unidentified Company Representative

Great to see you, too. Thanks for having us.

Unidentified Company Representative

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot